Fight the New Drug Inc

Balance Sheet
Fiscal Year: 2024
Assets in 2024 (Year End)
$143,416
Other Assets
52%
Inventories
19%
Cash & Equivalents
15%
Property, Plant, & Equipment (net)
11%
Prepaid Expenses
2%
Receivables (Non-Related)
2%
Related-Party Receivables
0%
Investments
0%
Liabilities in 2024 (Year End)
$84,325
Notes Payable / Debt (Non-Related)
83%
Payables & Accruals
17%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$283,250
$21,294
-92%
Receivables (Non-Related)
$18,168
$2,594
-86%
Related-Party Receivables
-
-
-
Inventories
$28,699
$27,011
-6%
Prepaid Expenses
$5,337
$2,614
-51%
Investments
-
-
-
Property, Plant, & Equipment (net)
$17,319
$15,188
-12%
Other Assets
$3,862
$74,715
+1835%
Total Assets
$356,635
$143,416
-60%
Liabilities
2023
2024
Change
Payables & Accruals
$47,540
$14,313
-70%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$15,449
$70,012
+353%
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$62,989
$84,325
+34%
Net assets
2023
2024
Change
Restricted Net Assets
$30,000
$0
-100%
Unrestricted Net Assets
$263,646
$59,091
-78%
Net assets
2023
2024
Change
Net assets
+$293,646
+$59,091
-80%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)